BMEA
Biomea Fusion, Inc. · Healthcare
A2A Pharmaceuticals, Inc. sold $8.6M of Biomea Fusion, Inc.
10% owner
Sold$8,575,030
$34.30Price
250,000Shares
−6%Stake
What BMEA did after the filing
- The stock from Wed, May 10 close, $32.98
- −7.0%
- S&P 500, same days
- +5.3%
Measured over 30 trading days, to the Jun 23 close.
Traded Mon, May 8. Filed Wed, May 10, 1:19 PM ET, during the session. Returns use the May 10 close and the Jun 23 close. Not investment advice.